News | February 19, 2021
Dr. Reddy's Laboratories launches FH Tablets in the U.S. Market
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Its a major breakthrough for women’s ovarian cancer care in Europe
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The new assay consolidates screening for four major viral threats into a single workflow
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
Subscribe To Our Newsletter & Stay Updated
